Blood samples can soon reveal your lifestyle

09 Mar 2018

1

People who use moist snuff 'snus' have significantly higher levels of the protein cornulin in their blood than non-snusers.

This previously unknown relationship was found in a new study from Umeå University, Sweden. Whether higher levels per se increase the risk of disease has, however, not yet been clarified.

"It's important to know about this type of association if you want to use blood-based markers for disease. For some markers, acceptable limits might have to be individualized, since lifestyle factors can influence background levels," says Robin Myte, doctoral student at Umeå University and one of the researchers behind the study.

Scientists at Umeå University investigated whether a person's lifestyle can be reflected in the blood levels of 160 different proteins. The study is based on blood samples and lifestyle data collected during health examinations in the Västerbotten Intervention Programme in northern Sweden.

It is now possible to measure the levels of hundreds of proteins in less than a drop of blood. The scientists hope that one or more of the proteins included in the study may some day be used to detect and predict diseases such as diabetes, cardiovascular disease or cancer.

Previous studies have shown that tobacco habits, physical activity and alcohol consumption affect health, and probably also the protein composition in the blood. But the relationships among them are largely unknown.

For each of the 138 participants in the study, two blood samples, collected ten years apart, were analysed. Several proteins were linked to different lifestyle behaviours. The strongest finding was that snusers had significantly higher levels of the protein cornulin compared to non-snusers.

Swedish snus, also called moist snuff, is a finely ground, moistened smokeless tobacco product, placed in a lump or tea-bag-like portion between the lip and the gum.

Cornulin is a protein that is produced mainly in the mouth and throat by cells exposed to external stress. The newly discovered relationship between snus and cornulin levels was completely independent of whether or not the participants were smokers.

The association was also confirmed in another study, through collaboration with researchers from Uppsala University. The consistent results increase the reliability of the finding. On the other hand, it is still unclear whether the higher cornulin levels in snusers are linked to an increased risk of disease.

"Protein markers are an exciting tool for diagnosis and early detection of diseases, but protein levels may vary due to many different factors. That is why we aimed to map some of the 'normal' variation in protein levels in our study," says Robin Myte.

Latest articles

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Indians can now travel to 56 destinations without prior visa as passport ranking improves

Indians can now travel to 56 destinations without prior visa as passport ranking improves

CEO says EU’s IRIS2 must match Starlink on price and performance

CEO says EU’s IRIS2 must match Starlink on price and performance

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Opening the silos: India approves 3 million tonnes of wheat and product exports

Opening the silos: India approves 3 million tonnes of wheat and product exports

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round